PeerView Endocrinology & Diabetes CME/CNE/CPE Audio Podcast
by PVI, PeerView Institute for Medical Education
Is this your podcast?Insights from recent episode analysis
Audience Interest
Podcast Focus
Publishing Consistency
Platform Reach
Insights are generated by CastFox AI using publicly available data, episode content, and proprietary models.
Most discussed topics
Brands & references
Est. Listeners
Insufficient chart data. Estimates will improve as the show charts.
- Per-Episode Audience
Est. listeners per new episode within ~30 days
N/A🎙 ~2x weekly·51 episodes·Last published 1mo ago - Monthly Reach
Unique listeners across all episodes (30 days)
N/A - Active Followers
Loyal subscribers who consistently listen
N/A
Market Insights
Platform Distribution
Reach across major podcast platforms, updated hourly
Total Followers
—
Total Plays
—
Total Reviews
—
* Data sourced directly from platform APIs and aggregated hourly across all major podcast directories.
On the show
From 12 epsHost
Recent guests
Recent episodes
Athena Philis-Tsimikas, MD - Betting on Basal Insulin: Improving the Odds for People With Type 2 Diabetes (Updates From Las Vegas)
May 25, 2026
1h 08m 39s
Christina Y. Weng, MD, MBA - Reimagining Retinal Treatment: The Promise of Novel Delivery Mechanisms for Anti-VEGF Therapies
May 12, 2026
35m 36s
Jay H. Shubrook, DO, FAAFP, FACOFP - Unlocking the Potential of Incretin-Based Therapies in T2D: Comprehensive Primary Care Strategies for Cardiometabolic Health
May 7, 2026
1h 25m 04s
Prof. Chantal Mathieu, MD, PhD - Betting on Basal Insulin: Improving the Odds for People With Type 2 Diabetes
Apr 3, 2026
1h 07m 20s
Peter A. Campochiaro, MD / Diana V. Do, MD - Innovations in Retinal Vascular Diseases: Enhancing Patient Outcomes Through Longer-Acting Therapies and Precision Dosing
Mar 24, 2026
57m 25s
Social Links & Contact
Official channels & resources
Official Website
Login
RSS Feed
Login
| Date | Episode | Topics | Guests | Brands | Places | Keywords | Sponsor | Length | |
|---|---|---|---|---|---|---|---|---|---|
| 5/25/26 | Athena Philis-Tsimikas, MD - Betting on Basal Insulin: Improving the Odds for People With Type 2 Diabetes (Updates From Las Vegas)✨ | basal insulintype 2 diabetes+3 | Athena Philis-Tsimikas, MD | PVI, PeerView Institute for Medical EducationAccreditation Council for Continuing Medical Education (ACCME)+2 | — | basal insulintype 2 diabetes+4 | Lilly | 1h 08m 39s | |
| 5/12/26 | Christina Y. Weng, MD, MBA - Reimagining Retinal Treatment: The Promise of Novel Delivery Mechanisms for Anti-VEGF Therapies✨ | retinal treatmentanti-VEGF therapies+3 | Christina Y. Weng, MD, MBA | PeerView Institute for Medical EducationAccreditation Council for Continuing Medical Education+3 | — | retinal treatmentanti-VEGF+3 | Genentech | 35m 36s | |
| 5/7/26 | Jay H. Shubrook, DO, FAAFP, FACOFP - Unlocking the Potential of Incretin-Based Therapies in T2D: Comprehensive Primary Care Strategies for Cardiometabolic Health✨ | Incretin-based therapiesType 2 diabetes+3 | Jay H. Shubrook, DO, FAAFP, FACOFP | PVI, PeerView Institute for Medical EducationAccreditation Council for Continuing Medical Education (ACCME)+2 | — | incretinType 2 diabetes+6 | Lilly | 1h 25m 04s | |
| 4/3/26 | Prof. Chantal Mathieu, MD, PhD - Betting on Basal Insulin: Improving the Odds for People With Type 2 Diabetes✨ | basal insulintype 2 diabetes+3 | Prof. Chantal Mathieu, MD, PhD | PVI, PeerView Institute for Medical EducationAccreditation Council for Continuing Medical Education (ACCME)+2 | — | basal insulintype 2 diabetes+4 | Lilly | 1h 07m 20s | |
| 3/24/26 | Peter A. Campochiaro, MD / Diana V. Do, MD - Innovations in Retinal Vascular Diseases: Enhancing Patient Outcomes Through Longer-Acting Therapies and Precision Dosing✨ | retinal vascular diseasespatient outcomes+3 | Peter A. Campochiaro, MDDiana V. Do, MD | PeerView Institute for Medical EducationAccreditation Council for Continuing Medical Education+2 | — | retinal diseasespatient care+4 | Regeneron Pharmaceuticals, Inc. | 57m 25s | |
| 11/20/25 | John B. Buse, MD, PhD / Pam R. Taub, MD, FACC, FASPC - To Glycemia and Beyond: Managing Cardiovascular Risk in People With Type 2 Diabetes Using Incretin-Based Therapies✨ | Type 2 DiabetesCardiovascular Risk+3 | John B. Buse, MD, PhDPam R. Taub, MD, FACC, FASPC | PeerView Institute for Medical EducationAccreditation Council for Continuing Medical Education+2 | — | glycemiacardiovascular risk+3 | Lilly | 1h 03m 31s | |
| 10/30/25 | Arun J. Sanyal, MBBS, MD - Making Connections to Improve Patient Care in Obesity, Metabolism, and Liver Health✨ | patient careobesity+3 | Arun J. Sanyal, MBBS, MD | PVI, PeerView Institute for Medical EducationObesity Medicine Association+3 | — | CMEhealthcare professionals+4 | Boehringer Ingelheim Pharmaceuticals, Inc. | 44m 00s | |
| 10/27/25 | Alexis Ogdie, MD, MSCE, Robert H. Eckel, MD, FAHA, FACC - Tackling Obesity in Psoriatic Arthritis: Key to Better Outcomes and Overall Health✨ | ObesityPsoriatic Arthritis+3 | Alexis Ogdie, MD, MSCERobert H. Eckel, MD, FAHA, FACC | PVI, PeerView Institute for Medical EducationAccreditation Council for Continuing Medical Education (ACCME)+2 | — | obesitypsoriatic arthritis+5 | Lilly | 56m 09s | |
| 7/21/25 | Joseph M. Coney, MD, FACS, FASRS - Eye on Equity: A Comprehensive Approach to DR/DME Care in Under-Represented Populations✨ | Diabetic RetinopathyDiabetic Macular Edema+3 | Joseph M. Coney, MD, FACS, FASRS | PeerView Institute for Medical EducationAccreditation Council for Continuing Medical Education (ACCME)+3 | — | DRDME+3 | Genentech | 50m 39s | |
| 5/6/25 | Professor Melanie Davies - Seeing Beyond the Numbers in Type 2 Diabetes: Empowering Patients for Optimal Weight and Glycaemic Management✨ | Type 2 DiabetesPatient Empowerment+3 | Professor Melanie Davies | PeerView Institute for Medical EducationAccreditation Council for Continuing Medical Education+2 | — | Type 2 DiabetesPatient Care+5 | Lilly | 59m 29s | |
Want analysis for the episodes below?Free for Pro Submit a request, we'll have your selected episodes analyzed within an hour. Free, at no cost to you, for Pro users. | |||||||||
| 4/1/25 | Professor Carel le Roux, MBChB, FRCP, FRCPath, PhD / Donna H. Ryan, MD, FTOS - Adopting Modern Management Strategies for Obesity: Treating the Patient, Not the Disease✨ | obesity managementpatient care+3 | Professor Carel le Roux, MBChB, FRCP, FRCPath, PhDDonna H. Ryan, MD, FTOS | PVI, PeerView Institute for Medical EducationAccreditation Council for Continuing Medical Education (ACCME)+2 | — | obesitypatient treatment+5 | Lilly | 1h 02m 40s | |
| 3/19/25 | Angela Fitch, MD, FACP, FOMA - Breaking Through Biases in Obesity Management: Building Competence, Creating Connections, and Empowering Leaders in Primary Care✨ | obesity managementhealthcare education+4 | Angela Fitch, MD, FACP, FOMA | PVI, PeerView Institute for Medical EducationAccreditation Council for Continuing Medical Education (ACCME)+2 | — | obesityhealthcare+6 | Lilly | 1h 05m 15s | |
| 2/10/25 | Lucia M. Novak, MSN, ANP-BC, BC-ADM - Individualizing Management Plans for Type 2 Diabetes Through Shared Decision-Making: An Office Hours Activity | This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/NCPD/AAPA information, and to apply for credit, please visit us at PeerView.com/UTJ865. CME/NCPD/AAPA credit will be available until February 28, 2026.Individualizing Management Plans for Type 2 Diabetes Through Shared Decision-Making: An Office Hours Activity In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by an educational grant from Lilly.Disclosure information is available at the beginning of the video presentation. | — | ||||||
| 1/31/25 | Professor Melanie Davies - Understanding the Individual in Front of You: The Importance of Patient Participation in Weight and Glycaemic Management for People With Type 2 Diabetes | This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME information, and to apply for credit, please visit us at PeerView.com/EYG865. CME credit will be available until January 23, 2026.Understanding the Individual in Front of You: The Importance of Patient Participation in Weight and Glycaemic Management for People With Type 2 Diabetes In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by an educational grant from Lilly.Disclosure information is available at the beginning of the video presentation. | — | ||||||
| 1/3/25 | Vanita R. Aroda, MD - Intensifying Treatment for Type 2 Diabetes According to Current Guidelines: An Office Hours Activity | This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/NCPD/AAPA information, and to apply for credit, please visit us at PeerView.com/NRC865. CME/NCPD/AAPA credit will be available until January 11, 2025.Intensifying Treatment for Type 2 Diabetes According to Current Guidelines: An Office Hours Activity In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by an educational grant from Lilly.Disclosure information is available at the beginning of the video presentation. | — | ||||||
| 12/9/24 | Javed Butler, MD, MPH, MBA / Muthiah Vaduganathan, MD, MPH - Experts vs AI: Exploring New Paradigms in Comprehensive Care for Cardio-Renal-Metabolic Diseases | This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME information, and to apply for credit, please visit us at PeerView.com/RWH865. CME credit will be available until December 16, 2025.Experts vs AI: Exploring New Paradigms in Comprehensive Care for Cardio-Renal-Metabolic Diseases In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by an independent medical educational grant from Boehringer Ingelheim Pharmaceuticals, Inc. and Eli Lilly and Company.Disclosure information is available at the beginning of the video presentation. | — | ||||||
| 11/11/24 | Guillermo E. Umpierrez, MD, CDE, FACP, FACE - Prioritizing Weight Management as a Primary Goal in People With Type 2 Diabetes: An Office Hours Activity | This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/NCPD/AAPA information, and to apply for credit, please visit us at PeerView.com/RWC865. CME/NCPD/AAPA credit will be available until November 29, 2025.Prioritizing Weight Management as a Primary Goal in People With Type 2 Diabetes: An Office Hours Activity In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by an educational grant from Lilly.Disclosure information is available at the beginning of the video presentation. | — | ||||||
| 11/11/24 | Irl Hirsch, MD, MACP - The New Normal: Digital Technologies for People Living With Insulin-Treated Type 2 Diabetes | This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/NCPD/AAPA information, and to apply for credit, please visit us at PeerView.com/UHT865. CME/NCPD/AAPA credit will be available until October 31, 2025.The New Normal: Digital Technologies for People Living With Insulin-Treated Type 2 Diabetes In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by an educational grant from Novo Nordisk Inc.Disclosure information is available at the beginning of the video presentation. | — | ||||||
| 8/28/24 | John E. Anderson, MD - Conversations With Peers About T2DM: Best Practices for Optimizing Treatment Using Weight Management as a Primary Goal | This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/NCPD/AAPA information, and to apply for credit, please visit us at PeerView.com/USQ865. CME/NCPD/AAPA credit will be available until August 15, 2025.Conversations With Peers About T2DM: Best Practices for Optimizing Treatment Using Weight Management as a Primary Goal In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by an educational grant from Lilly.Disclosure information is available at the beginning of the video presentation. | — | ||||||
| 8/20/24 | P. Barton Duell, MD - Lipid Management Beyond Statins: Early Screening, Prompt Intervention, and Timely Intensification With PCSK9-Targeted Therapies | This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME information, and to apply for credit, please visit us at PeerView.com/QMF865. CME credit will be available until August 15, 2025.Lipid Management Beyond Statins: Early Screening, Prompt Intervention, and Timely Intensification With PCSK9-Targeted Therapies In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by an educational grant from Novartis Pharmaceuticals Corporation.Disclosure information is available at the beginning of the video presentation. | — | ||||||
| 6/19/24 | Javier Morales, MD, FACP, FACE - Cases in the Community: Optimizing Treatment and Considering Weight Management as a Primary Goal in People with T2DM | This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/CE/AAPA information, and to apply for credit, please visit us at PeerView.com/ZKT865. CME/CE/AAPA credit will be available until June 11, 2025.Cases in the Community: Optimizing Treatment and Considering Weight Management as a Primary Goal in People with T2DM In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by an educational grant from Lilly.Disclosure information is available at the beginning of the video presentation. | — | ||||||
| 3/28/24 | Javier Morales, MD, FACP, FACE - Conversations With Peers About T2DM: Best Practices for Optimizing Treatment Using Weight Management as a Primary Goal | This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/NCPD/AAPA information, and to apply for credit, please visit us at PeerView.com/WMV865. CME/NCPD/AAPA credit will be available until March 25, 2025.Conversations With Peers About T2DM: Best Practices for Optimizing Treatment Using Weight Management as a Primary Goal In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by an educational grant from Lilly.Disclosure information is available at the beginning of the video presentation. | — | ||||||
| 2/28/24 | R. Scott Wright, MD - Targeting Elevated Cardiovascular Risk: Current Therapies and New Horizons in Hyperlipidemia Management | This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME information, and to apply for credit, please visit us at PeerView.com/GVK865. CME credit will be available until February 13, 2025.Targeting Elevated Cardiovascular Risk: Current Therapies and New Horizons in Hyperlipidemia ManagementThe University of Florida College of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.This activity is developed in collaboration with our educational partner, PVI, PeerView Institute for Medical Education.SupportThis activity is supported by an educational grant from Novartis Pharmaceuticals Corporation.DisclosuresR. Scott Wright, MD, has a financial interest/relationship or affiliation in the form of:Consultant and/or Advisor for Boehringer Ingelheim Pharmaceuticals, Inc.; Novartis Pharmaceuticals Corporation; and Novo Nordisk Inc.CME ReviewerRamil GoelAssistant Professor of MedicineDivision of Cardiovascular MedicineElectrophysiology SectionUniversity of Florida College of MedicineGainesville, FloridaRamil Goel, MD, FHRS, has no relevant financial relationships to disclose. | — | ||||||
| 1/31/24 | Professor Benjamin Solomon, MBBS, PhD, FRACP, FAHMS - Adapting Our Strategies for Decision-Making in Testing and Treatment of RET-Altered Lung and Thyroid Cancers: A Personalized Learning Journey | This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/CC/NCPD/CPE/AAPA/IPCE information, and to apply for credit, please visit us at PeerView.com/ANR865. CME/MOC/CC/NCPD/CPE/AAPA/IPCE credit will be available until January 16, 2025.Adapting Our Strategies for Decision-Making in Testing and Treatment of RET-Altered Lung and Thyroid Cancers: A Personalized Learning Journey In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by an educational grant from Lilly.Disclosure PolicyAll relevant conflicts of interest have been mitigated prior to the commencement of the activity.Faculty/Planner DisclosuresCo-Chair/PlannerProfessor Benjamin Solomon, MBBS, PhD, FRACP, FAHMS, has a financial interest/relationship or affiliation in the form of:Consultant and/or Advisor for Amgen Inc.; AstraZeneca; Bristol Myers Squibb; D3 BIO, INC; F. Hoffmann-La Roche AG; Janssen Pharmaceuticals, Inc.; Lilly; Merck Sharpe & Dohme; Pfizer; and Takeda Pharmaceutical Company.Speakers Bureau participant with AstraZeneca; F. Hoffmann-La Roche AG; and Pfizer.Co-Chair/PlannerLori J. Wirth, MD, has a financial interest/relationship or affiliation in the form of:Consultant and/or Advisor for AbbVie Inc.; Bayer HealthCare Pharmaceuticals Inc.; Blueprint Medicines Corporation; Coherus BioSciences; Eisai Co., Ltd.; Ellipses Pharma Ltd; EMD Serono, Inc.; Exelixis, Inc.; Lilly; Merck & Co., Inc.; and Nested Therapeutics.Data Safety Monitoring Board for PDS Biotechnology.Planning Committee and Reviewer DisclosuresPlanners, independent reviewers, and staff of PVI, PeerView Institute for Medical Education, do not have any relevant financial relationships related to this CE activity unless listed below. | — | ||||||
| 1/4/24 | Stefano Del Prato, MD - Tools of the Trade: Prioritising Weight Management in People With Type 2 Diabetes – Sharpening Your Skills to Intensify Therapy and Engage in Shared Decision-Making | This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/CPD information, and to apply for credit, please visit us at PeerView.com/BVW865. CME/CPD credit will be available until December 27, 2024.Tools of the Trade: Prioritising Weight Management in People With Type 2 Diabetes – Sharpening Your Skills to Intensify Therapy and Engage in Shared Decision-Making In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by an educational grant from Lilly.Disclosure PolicyAll relevant conflicts of interest have been mitigated prior to the commencement of the activity.Faculty/Planner DisclosuresChair/PlannerStefano Del Prato, MD, has a financial interest/relationship or affiliation in the form of:Consultant and/or Advisor for Abbott; Amarin Corporation plc; Applied Therapeutics; EvaPharma; Lilly; The Menarini Group; Novo Nordisk A/S; Sanofi; and Sun Pharmaceutical Industries Ltd.Speaker for Abbott; AstraZeneca; Berlin-Chemie AG; Boehringer Ingelheim International GmbH; Laboratori Guidotti S.p.a.; Lilly; The Menarini Group; Merck Sharp & Dohme; and Novo Nordisk A/S.Planning Committee and Reviewer DisclosuresPlanners, independent reviewers, and staff of PVI, PeerView Institute for Medical Education, do not have any relevant financial relationships related to this CE activity unless listed below. | — | ||||||
Showing 25 of 54
Pitch Fit is a Pro feature
See how bookable this show is for guests, which brands already advertise, the per-episode ad value, and the best-fit guest and sponsor profile. The numbers are blurred on the free plan.
How readily this show books outside guests like you.
How proven this show is for host-read sponsorships.
For Guests
ProFor Advertisers
ProUpgrade to Pro to unlock guest cadence, sponsor categories, fit scores, and per-episode ad value for this show.